§ BIOTECHNOLOGY
USD · BiotechnologyJANX
JANUX THERAPEUTICS INC
USDSector · BiotechnologyBeta · 2.37
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
127 increased/new, 50 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 3.02 | EPS (TTM) | -1.64 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11.2M | 1.6% | ±0% |
| BlackRock, Inc. | 5.4M | 0.0% | +33% |
| JANUS HENDERSON GROUP PLC | 4.2M | n/a | −22% |
| Prosight Management, LP | 3.5M | 8.1% | +48% |
| Fidelity Management | 2.5M | 0.0% | −28% |
| State Street | 2.5M | 0.0% | −36% |
◇ AC INTELLIGENCE
Top institutional owners for JANX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER64.8% · 122 holders
QUALITY / COMPOUNDER19.5% · 14 holders
PASSIVE / INDEX11.7% · 8 holders
DEALER / BANK9.7% · 25 holders
TACTICAL / MACRO3.4% · 5 holders
SYSTEMATIC / QUANT1.3% · 7 holders
INCOME / DEFENSIVE0.3% · 9 holders
ACTIVIST0.2% · 1 holder
GROWTH / MOMENTUM0.1% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for JANX in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention JANX yet.